Wedbush Securities’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-5,128
| Closed | -$84K | – | 1002 |
|
|
2019
Q4 | $84K | Buy |
5,128
+966
| +23% | +$15.8K | 0.01% | 938 |
|
|
2019
Q3 | $43K | Buy |
4,162
+1,562
| +60% | +$16.1K | ﹤0.01% | 945 |
|
|
2019
Q2 | $43K | Buy |
2,600
+1,125
| +76% | +$18.6K | ﹤0.01% | 953 |
|
|
2019
Q1 | $30K | Buy |
+1,475
| New | +$30K | ﹤0.01% | 911 |
|
|
2018
Q1 | – | Sell |
-698
| Closed | -$53K | – | 888 |
|
|
2017
Q4 | $53K | Sell |
698
-185
| -21% | -$14K | 0.01% | 819 |
|
|
2017
Q3 | $71K | Sell |
883
-453
| -34% | -$36.4K | 0.01% | 795 |
|
|
2017
Q2 | $81K | Buy |
1,336
+268
| +25% | +$16.2K | 0.01% | 781 |
|
|
2017
Q1 | $75K | Buy |
1,068
+643
| +151% | +$45.2K | 0.01% | 786 |
|
|
2016
Q4 | $32K | Buy |
+425
| New | +$32K | ﹤0.01% | 791 |
|